Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: Evidence for long-term clinical and molecular remissions

Leukemia

Volumn 13, Issue 9, 1999, Pages 1456-1462

  Tarella, C ^a   Corradini, P ^b   Astolfi, M ^b   Bondesan, P ^b   Caracciolo, D ^b   Cherasco, C ^b   Ladetto, M ^b   Giaretta, F ^b   Ricca, I ^b   Vitolo, U ^b   Pileri, A ^b   Ferrero, D ^b  

^a Cattedra di Ematologia   (Italy)

^b NONE

Author keywords

Ex vivo purging; Molecular remission; Non Hodgkin's lymphoma; PBPC autograft

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; CYCLOPHOSPHAMIDE; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW PURGING; CANCER CHEMOTHERAPY; CANCER REGRESSION; CELL SEPARATION; CLINICAL ARTICLE; CLINICAL TRIAL; DEVICE; FEMALE; FOLLICULAR LYMPHOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LEUKAPHERESIS; LYMPHOMA CELL; MALE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0032842482     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401488     Document Type: Article

References (44)

1. Armitage JO. Bone marrow transplantation for indolent lymphomas. Semin Oncol 1993; 20: 136-142.
2. Coiffier B. Towards a cure in indolent lymphoproliferative diseases? Eur J Cancer 1995; 31A: 2135-2137.
3. Freedman AS, Gribben JG, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Pandite L, Robertson MJ, Kroon M, Ritz J, Nadler LM. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood 1996; 88: 2780-2786.
4. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rablnowe SN, Coral F, Freeman GJ. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. New Engl J Med 1991; 325: 1525-1533.
5. Gribben JG, Neuberg D, Freedman AS, Gimrni CD, Pesek KW, Barber M, Saporito L, Woo SD, Coral F, Spector N. Detection by polymerase chain reaction of residual cells with the bol-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 81: 3449-3457.
6. Gianni AM, Bregni M, Siena S, Villa S, Sciorelli GA, Ravagnani F, Pellegris G, Bonadonna G. Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo-radiotherapy? Hematol Oncol 1989; 7: 139-148.
7. Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, Pileri A, Bonadonna G, Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; 2: 580-585.
8. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HM, Link H, Zander A, Barge A. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353-357.
9. Bastion Y, Brice P, Haioun C, Sonet A, Salles G, Marolleau JP, Espinouse D, Reyes F, Gisselbrecht C, Coiffier B. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 1995; 86: 3257-3262.
10. Bierman PJ, Vose JM, Anderson JR, Bishop MR, Kessinger A, Armitage JO. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol 1997; 15: 445-450.
11. Coiffier B, Philip T, Burnett AK, Symann ML. Consensus Conference on Intensive Chemotherapy Plus Hematopoietic Stem Cell Transplantation in Malignancies. Lyon, France, 4-6 June, 1993. J Clin Oncol 1994; 12: 226-231.
12. Haas R, Moos M, Mohle R, Dohner H, Witt B, Goldschmidt H, Murea S, Flentje M, Wannenmacher M, Hunstein W. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma. Bone Marrow Transplant 1996; 17: 149-155.
13. Tarella C, Gavarotti P, Caracciolo D, Corradini P, Cherasco C, Castellino C, Gallo E, Pileri A. Haematological support of high-dose sequential chemotherapy: clinical evidence for reduction of toxicity and high response rates in poor risk lymphomas. Ann Oncol 1995; 6: 3-8.
14. Gianni AM, Bregni M, Siena S, Brambilla C, Di Nicola M, Lombardi F, Gandola L, Tarella C, Pileri A, Ravagnani F, Valagussa P, Bonadonna G. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. New Engl J Med 1997; 336: 1290-1297.
15. Tarella C, Caracciolo D, Gavarotti P, Bondesan P, Cherasco C, Omede P, Bregni M, Siena S, Gianni AM, Pileri A. Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization. Bone Marrow Transplant 1995; 16: 223-228.
16. Corradini P, Astolfi M, Cherasco C, Ladetto M, Voena C, Caracciolo D, Pileri A, Tarella C. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. Blood 1997; 89: 724-731.
17. Corradini P, Astolfi M, Caracciolo D, Bondesan P, Voena C, Vitolo U, Cinque F, Pileri A, Tarella C. High-dose chemotherapy and PBPC autografting in indolent lymphomas: evaluation of minimal residual disease and molecular follow-up. Bone Marrow Transplant 1998; 21: 634a.
18. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 1995; 85: 1647-1654.
19. Gee A. Purging of peripheral blood stem cell grafts. Stem Cells 1995; 13: 52-62.
20. Lopez M, Lemoine F, Firat H, Fouillard L, Laporte JP, Lesage S, Isnard F, Stachowiak J, Ferrer-Le Coeur F, Morel P, Najman A, Douay L, Gorin NC. Bone marrow vs peripheral blood progenitor cells CD34 selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Implications for autografting. Blood 1997; 90: 2830-2838.
21. Ferrero D, Tarella C, Cherasco C, Bondesan P, Omede P, Ravaglia R, Caracciolo D, Castellino C, Pileri A. A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantation. Bone Marrow Transplant 1998; 21: 409-413.
22. Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni AM. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400-409.
23. Tarella C, Benedetti G, Caracciolo D, Castellino C, Cherasco C, Bondesan P, Omede P, Ruggieri D, Gianni AM, Pileri A. Both early and committed haemopoietic progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high-dose chemotherapy + G-CSF. Br J Haematol 1995; 91: 535-543.
24. Tarella C, Ferrero D, Bregni M, Siena S, Gallo E, Pileri A, Gianni AM. Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF. Eur J Cancer 1991; 27: 22-27.
25. Kvalheim G, Fjeld JG, Pihl A, Funderud S, Ugelstad J, Fodstad O, Nustad K. Immunomagnetic removal of B-lymphoma cells using a novel mono-sized magnetizable polymer oead, M-280, in conjunction with primary IgM and IgG antibodies. Bone Marrow Transplant 1989; 4: 567-574.
26. Corradini P, Voena C, Astolfi M, Ladetto M, Tarella C, Boccadoro M, Pileri A. High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. Blood 1995; 85: 1596-1602.
27. Gribben JG, Freedman AS, Woo SD, Blake KW, Shu RS, Freeman G, Longtine JA, Pinkus GS, Nadler LM. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 1991; 78: 3275-3280.
28. Gribben JG, Saporito L, Barber M, Blake KW, Edwards RM, Griffin JD, Freedman AS, Nadler LM. Bone marrows of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion. Blood 1992; 80: 1083-1089.
29. Andersen NS, Donovan JW, Borus JS, Poor CM, Neuberg D, Aster JC, Nadler LM, Freedman AS, Gribben JG, Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease. Blood 1997; 90: 4212-4221.
30. Voena C, Ladetto M, Astolfi M, Provan D, Gribben JG, Boccadoro M, Pileri A, Corradini P. A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors. Leukemia 1997; 11: 1793-1798.
31. Provan D, Bartlett-Pandite L, Zwicky C, Neuberg D, Maddocks A, Corradini P, Soiffer R, Ritz J, Nadler LM, Gribben JG. Eradication of polyrnerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood 1996; 88: 2228-2235.
32. Tarella C, Castellino C, Locatelli F, Caracciolo D, Corradini P, Falda M, Novarino A, Tassi V, Pileri A. G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs. Bone Marrow Transplant 1998; 21: 401-407.
33. Bensinger WI. Should we purge? Bone Marrow Transplant 1998; 21: 113-115.
34. + selection systems. Stem Cells 1997; 15: 297-304.
35. + cell separation systems. Bone Marrow Transplant 1997; 19: 1239-1246.
36. Shpall EJ, Gee A, Cagnoni PJ, Hogan C, Gehling U, Hami L, Franklin W, Bearman SI, Ross M, Jones RB. Stem cell isolation. Curr Opin Hematol 1995; 2: 452-459.
37. + progenitors in bone marrow of BCL2-lgH-positive follicular lymphoma patients. Blood 1995; 86: 4691-4698.
38. Rambaldi A, Borleri G, Dotti G, Bellavita P, Amaru R, Biondi A, Barbul T. Innovative two-step negative selection of granulocyte colony-stimulating factor-mobilized circulating progenitor cells: adequacy for autologous and allogeneic transplantation. Blood 1999; 91: 2189-2196.
39. Dreger P, von Neuhoff N, Suttorp M, Loffler H, Schmitz N. Rapid engraftment of peripheral blood progenitor cell grafts purged with B cell-specific monoclonal antibodies and immunomagnetic beads. Bone Marrow Transplant 1995; 16: 627-629.
40. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390-397.
41. Shpall EJ, Jones RB, Bearman SI, Franklin W, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. / Clin Oncol 1994; 12: 28-36.
42. Tarella C, Zallio F, Caracciolo D, Cherasco C, Bondesan P, Gavarotti P, Corradini P, Tassi V, Pileri A. Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patients. Stem Cells 1999; 17: 55-61.
43. + progenitor cells in low-grade lymphoma with Rituximab and high-dose chemotherapy. Blood 1999; 92: 119a.
44. Corradini P, Ladetto M, Astolfi M, Voena C, Tarella C, Bacigalupo A, Pileri A. Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphoma. Br J Haematol 1996; 94: 376-378.